Company logo
Get Listed

Exploring New Pancreatic Cancer Treatments: Breakthroughs and Hope

Discover groundbreaking treatments for pancreatic cancer. Explore innovative therapies offering hope for improved outcomes. Learn more now!

  • Cancer

By Shreya Sanas

16th Sept '22

Blog Banner Image

Cancer is a scary and life-threatening disease. The treatment options are limited for cancer, but if it is detected early, the chances of successful treatment can increase. Pancreatic cancer is not found until it has reached the advanced stages. This is because of the organ's location, and the doctors don't feel your pancreas while performing a routine check-up. So if you don't see any symptoms, cancer can go undetected for a while.


This question will definitely arise in your mind when we already have pancreatic cancer treatment. Well, let's read ahead to know it in a better way.

In the case of pancreatic cancer, no existing screening tests can detect pancreatic cancer in the earlier stages. The research is going on to develop a tool that can detect cancer earlier.

The main reason there is a need for a new treatment for pancreatic cancer is that this cancer is tough to treat. Research teams around the globe are trying to find new ways to treat this disease. 

Until recently, pancreatic cancer was treated using surgery, radiation therapy, and chemotherapy. These treatments were effective in treating systemic pancreatic cancer; it is cancer that has spread to the other parts of your body. 

Now, researchers are focusing on developing treatments that will be more targeted in how they will attack cancer cells. These developing medicines have the potential to fundamentally alter how doctors treat pancreatic cancer today and in the future, but more research is required.

Latest Treatment for Pancreatic Cancer 2022: New Hope

In a clinical trial project for groundbreaking pancreatic cancer treatment, medical experts from the Garvan Institute of Medical Research and the Australian biotechnology company Amplia Therapeutics are making a significant milestone.

They contend that the new targeted therapy can increase the susceptibility of cancer tumors to chemotherapy and raise patient survival rates.

The clinical trials can destroy the pancreatic tumor cancer cells for the novel medication AMP945.

The focus of AMP945 will be on the survival rates of patients with pancreatic ductal adenocarcinoma, one of the worst diseases in the world and an aggressive form of pancreatic cancer.

The 5-year survival rate is less than 10%, and if cancer has spread to other body areas, it will fall below 3%. 

What is the Strategy for Pancreatic Cancer New Treatment?

A protein produced by pancreatic cancer cells is the target of AMP945. The protein is known as focal adhesion kinase (FAK), which regulates fibrotic tissue growth.

Initial studies have produced encouraging results for the novel strategy of treating the tumor's surrounding tissue while also administering conventional chemotherapy.

“We wanted to try to improve chemotherapy by applying a novel strategy - targeting the environment around the tumor to make cancer more receptive to treatment,” says Dr. David Herrmann, co-leader of the study from Garvan's Invasion and Metastasis Lab.

At Garvan, preclinical studies showed that AMP945 could successfully inhibit FAK and reduce the stiffness and density of the connective tissue or stroma around cancer cells.

You must be interested to know how the study has been done. Let's read along..

How is the experiment done on the new drug for pancreatic cancer?

Experimental: AMP945

Part A: Cohorts of patients receiving AMP945 at increasing doses. 

Part B: Recommended phase 2 dosage for AMP945


Drug: AMP945 in escalating dosages

Part A is a phase 1b dose-escalation design that will enroll at least three patients in each of the four dose-level cohorts to assess the RP2D of AMP945, which will be evaluated in Part B. The dose-escalation decisions will be based on a standard 3+3 dose-escalation phase 1 oncology trial design.

Drug: AMP945 RP2D

The effectiveness of the AMP945 priming regimen at the recommended phase 2 dose (RP2D), as calculated in Part A, will be assessed in AMP945 RP2D Part B.

Outcome Measures:

Primary Outcome




Time Frame


Number of participants with TEAEs (Treatment Emergent Adverse Events) from baseline to End of the study


An average of six months should pass between the first study drug dose and its conclusion.


Part A: Determination of RP2D



Following Cycle 1 (28 days) for each cohort in Part A


Part B: efficacy of AMP945



Imaging every 56 days per participant, with an expected average duration of 6 months


Secondary Outcome




Time Frame


Part A: efficacy of AMP945


With an anticipated average duration of 6 months, imaging is performed every 56 days per participant.


AMP945 levels in plasma



Days -8, -7, 1, 3, 4, 8 and 10


AMP945 levels in plasma



Days -8, -7, 1, 3, 4, 8 and 10


AMP945 levels in plasma



Days -8, -7, 1, 3, 4, 8 and 10

Is any further trial required for this new drug for pancreatic cancer?

Yes. AMP945 trial is now recruiting people with advanced pancreatic cancer for the next trial. Notably those with inoperable pancreatic cancer or whose cancer has progressed to other parts of the body and has not previously had chemotherapy.

In an animal model using human pancreatic cancer cells, AMP945 increases the efficacy of the current standard of therapy.

Pre-treatment with AMP945 enhanced survival by 33% when used with the chemotherapy regimen of gemcitabine and Abraxane®.

Confirmation in a second animal model further supports the logic and layout of AMP945's Phase 2 human trial in people with first-line pancreatic cancer. In a recent news Amplia CEO and Managing Director, Dr. John Lambert said,

“Reaching a Phase 2 clinical trial milestone for AMP945 represents an important achievement for Australia’s medical research and biotechnology sector, signaling the translation of a novel therapy – discovered and developed by Australian scientists – into a tangible and potentially life-saving treatment for people with pancreatic cancer.”

Pancreatic cancer is one of the most challenging cancers to treat. It does not get detected until a progressed stage, so it is essential to have a new pancreatic cancer treatment as it is a life-threatening disease. The research for the new drug for pancreatic cancer can be beneficial in saving people's lives.


Frequently Asked Questions

What are the symptoms of pancreatic cancer?

What are the risk factors associated with the development of pancreatic cancer?

What is the survival rate of pancreatic cancer?

How long does it take for pancreatic cancer to go from Stage 1 to Stage 4?

What are the symptoms of the last stages of pancreatic cancer?

How is pancreatic cancer diagnosed?

What are the symptoms of pancreatic cancer?

What are the risk factors associated with the development of pancreatic cancer?

Relevant Blogs

Blog Banner Illustration

Dr. Sandeep Nayak - Best Oncologist in Bangalore

Dr. Sandeep Nayak - Best oncologist in Bangalore. Experience of 19 years. Consults at Fortis, MACS & Ramakrishna. To book an appointment, call @ +91-98678 76979

Blog Banner Image

Eye Cancer Treatment in India: Advanced Care Solutions

Explore advanced eye cancer treatment in India. Renowned specialists, state-of-the-art facilities ensure comprehensive care and better outcomes. Discover options today!

Blog Banner Image

PET Scan in Mumbai: Revealing Insights with Advanced Imaging

You’ll find all the available details for the PET scan in Mumbai on this page.

Blog Banner Image

Cancer Treatment in India: Costs, Hospitals, Doctors 2024

Discover cutting-edge cancer treatment in India. Renowned specialists, advanced technology ensure comprehensive care and better outcomes. Explore options today!

Blog Banner Illustration

Organ Specific Cancer Treatment in India

Organ-specific cancer treatment in India. Explore cutting-edge therapies, compassionate care, and renewed possibilities for healing. Learn more now!

Blog Banner Image

Best Medical Tourism Companies in India 2024 List

Discover excellence in healthcare with top-rated Medical Tourism Companies in India. Your journey to world-class treatment begins here.

Blog Banner Image

10 Best Hospitals in Istanbul - Updated 2023

Looking for the best hospital in Istanbul? Here is a compact list for you of the 10 Best Hospitals in Istanbul.

Blog Banner Image

15 Best Places of Hair Donation for Cancer Patients in India

Explore the best places for hair donation for cancer patients in India. Join the meaningful movement with our guide to Hair Donation for Cancer Patients in India, making a positive impact with every strand

Question and Answers

I want to chat with an oncologist i want to show a pet-scan report to him for advice

Female | 52

You can approach an oncologist via an appointment to further discuss a PET scan report if you need professional advice. This qualified doctor is best equipped to help you decipher the results. 

Answered on 8th Apr '24

Dr. Donald Babu

Dr. Donald Babu

I have blushing on my chest that come and go after cool down the redness gone completely but I also have lump underneath of lower inner quadrant of right breast I have this lump since 5 years is it sign of cancer

Female | 18

I recommend you to go to the breast specialist urgently to get a full diagnostic examination. Mass in the breast may be a sign of breast cancer, but not all the causes are the same.

Answered on 4th Apr '24

Dr. Ganesh Nagarajan

Dr. Ganesh Nagarajan

If I have a mastectomy do I need chemo?

Female | 33

That will depend on the cancer's type, how advanced it is, and if it has spread. Ask your medical team they will suggest the best treatment plan based on your specific situation.

Answered on 26th Mar '24

Dr. Donald Babu

Dr. Donald Babu

Answered on 26th Mar '24

Dr. Donald Babu

Dr. Donald Babu

Cost Of Related Treatments In Country